Target
Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]
Ligand
BDBM695326
Substrate
n/a
Meas. Tech.
In-Vitro Biochemical Assays
IC50
2.00±n/a nM
Citation
 Bordas, VBrocklehurst, CChene, PFuret, PGuagnano, VImbach-Weese, PKallen, JLe Douget, MLorthiois, ELMcKenna, JSalem, BSchmelzle, TSellner, HSoldermann, NVoegtle, MWartmann, M Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors US Patent  US12083101 Publication Date 9/10/2024 
Target
Name:
Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]
Synonyms:
Transcriptional coactivator (YAP)/Tafazzin (TAZ)- Transcriptional enhancer factor TEF-3 (TEAD4)
Type:
Protein
Mol. Mass.:
n/a
Description:
n/a
Components:
This complex has 3 components.
Component 1
Name:
Transcriptional enhancer factor TEF-3 [217-434]
Synonyms:
Transcriptional enhancer factor TEF-3 (TEAD4)(217-434)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25409.87
Organism:
Human
Description:
Q15561[217-434]
Residue:
218
Sequence:
RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE
  
Component 2
Name:
Transcriptional coactivator YAP1 [60-100]
Synonyms:
Transcriptional coactivator YAP1 (60-100)
Type:
Protein
Mol. Mass.:
4644.27
Organism:
Homo sapiens (Human)
Description:
P46937[60-100]
Residue:
41
Sequence:
DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE
  
Component 3
Name:
Tafazzin
Synonyms:
Protein G4.5 | Taz
Type:
Protein
Mol. Mass.:
30216.65
Organism:
Human
Description:
Q16635
Residue:
262
Sequence:
MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR
  
Inhibitor
Name:
BDBM695326
Synonyms:
US12083101, Example 64a
Type:
Small organic molecule
Emp. Form.:
n/a
Mol. Mass.:
n/a
SMILES:
NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CN[C@H]3C[C@H](CO)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.36,20.20,wD:22.23,(2.54,3.92,;1.2,3.15,;1.97,1.81,;-.13,3.92,;-.13,5.46,;-1.47,6.23,;-2.8,5.46,;-4.13,6.23,;-5.47,5.46,;-6.8,6.23,;-8.13,5.46,;-2.8,3.92,;-4.13,3.15,;-1.47,3.15,;-1.47,1.61,;-.13,.84,;1.33,1.31,;2.24,.07,;3.33,-1.02,;2.93,-2.51,;4.02,-3.6,;5.56,-3.6,;5.56,-5.14,;6.65,-6.23,;8.13,-5.83,;4.02,-5.14,;1.33,-1.18,;-.13,-.7,;-1.47,-1.47,;-2.8,-.7,;-4.13,-1.47,;-2.8,.84,;-4.13,1.61,;3.78,.07,;4.55,-1.27,;6.09,-1.27,;6.86,.07,;6.09,1.4,;4.55,1.4,)|
Structure:
Search PDB for entries with ligand similarity: